FUSO PHARMACEUTICAL INDUSTRIES financial statements, including revenue, expenses, profit, and loss
The total revenue of 4538 for the last quarter is 15.12 B JPY, and it's 3.39% higher compared to the previous quarter. The net income of Q2 24 is 903.00 M JPY.